Heartflow Unveils AI-Driven Plaque Analysis Data Predicting Cardiovascular Outcomes at AHA 2025
Heartflow Inc. has announced that it will present new late-breaking data on its AI-powered Heartflow Plaque Analysis at the American Heart Association (AHA) Scientific Sessions 2025, scheduled for November 7-10 in New Orleans. The data will focus on the clinical and economic value of Heartflow Plaque Analysis and its precision in predicting long-term cardiovascular outcomes. The featured study, titled "Coronary CT Angiography Plaque as a Predictor of Death, Cardiovascular Death and Myocardial Infarction," will be presented by Timothy Fairbairn, M.D., on November 9. The results of the study are currently under embargo and will be disclosed during the scheduled presentation.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartflow Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9566742-en) on November 03, 2025, and is solely responsible for the information contained therein.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。